1,370 results on '"Lenz, Heinz‐Josef"'
Search Results
2. Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors
3. Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors
4. Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
5. Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial
6. Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
7. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes
8. q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics
9. A revised nomenclature for the lemur family of protein kinases
10. Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer
11. Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality
12. Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial
13. Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia
14. Sexual dysfunction among early-onset colorectal cancer survivors: Sex-specific correlates of sexual health discussions between patients and providers
15. The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland Colorectal Cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO
16. Non-canonical MLL1 activity regulates centromeric phase separation and genome stability
17. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets
18. Cetuximab in the management of colorectal cancer
19. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
20. Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
21. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study
22. PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
23. Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer
24. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions
25. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes
26. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
27. Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials
28. Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database
29. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
30. Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
31. DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma
32. Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes
33. Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial
34. Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials
35. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
36. Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995–2018
37. Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis
38. Plant-based diet and survival among patients with metastatic colorectal cancer.
39. Clinical Applications of Circulating Tumor DNA Profiling in GI Cancers.
40. Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.
41. Reprogramming CBX8-PRC1 function with a positive allosteric modulator
42. ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
43. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
44. Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer
45. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
46. Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study
47. Evaluating the impact of age on immune checkpoint therapy biomarkers
48. Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy
49. Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer
50. Human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.